CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hubei Biocause Pharmaceutical Co., Ltd. Company Snapshot
Hubei Biocause Pharmaceutical Co., Ltd. operates in the Industrial organic chemicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hubei Biocause Pharmaceutical Co., Ltd. with three other companies in this sector in China: Zhejiang Jiaao Enprotech Stock Co Ltd (2015 sales of 511.62 million Chinese Renmimbi [US$74.33 million] ), JiangXi ChangJiu Biochemical Industry Company Limited (542.31 million Chinese Renmimbi [US$78.79 million] of which 96% was Industry), and Changmao Biochemical Engineering Co Ltd (514.78 million Chinese Renmimbi [US$74.79 million] of which 100% was Sales of goods).

Sales Analysis. Hubei Biocause Pharmaceutical Co., Ltd. reported sales of 541.07 million Chinese Renmimbi (US$78.61 million) for the year ending December of 2015. This represents a sharp decrease of 32.9% versus 2014, when the company's sales were 806.17 million Chinese Renmimbi. Contributing to the drop in overall sales was the 52.4% decline in Chemical Manufacturing, from 511.70 million Chinese Renmimbi to 243.56 million Chinese Renmimbi. . However, these declines were partially offset by the increase in sales of Pharmaceutical Manufacturing (up 0.9% to 297.54 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hubei Biocause Pharmaceutical Co., Ltd.
  Stock Performance Chart for Hubei Biocause Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 7.53
(Figures in Chinese Renmimbi)
1 Week -1.7%   13 Weeks -3.8%  
4 Weeks -2.2%   52 Weeks -7.0%  
 
Hubei Biocause Pharmaceutical Co., Ltd. Key Data:
  Ticker: 000627 Country: China
  Exchanges: SZN Major Industry: Materials
    Sub Industry: Chemicals & Allied Products
  2015 Sales 541,065,546
(Year Ending Jan 2016).
Employees: 1,428
  Currency: Chinese Renmimbi Market Cap: 32,071,735,082
  Fiscal Yr Ends: December Shares Outstanding: 4,259,194,566
  Share Type: A Gu Closely Held Shares: 3,273,559,384
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.